Abstract:Objective: Lung adenocarcinoma poses a major global health challenge and is a leading cause of cancer-related deaths worldwide. This study is a review of three molecular biomarkers screened by machine learning that are not only important in the occurrence and progression of lung adenocarcinoma but also have the potential to serve as biomarkers for clinical diagnosis, prognosis evaluation and treatment guidance. Methods: Differentially expressed genes (DEGs) were identified using comprehensive GSE1987 and GSE18842 gene expression databases. A comprehensive bioinformatics analysis of these DEGs was conducted to explore enriched functions and pathways, relative expression levels, and interaction networks. Random Forest and LASSO regression analysis techniques were used to identify the three most significant target genes. The TCGA database and quantitative polymerase chain reaction (qPCR) experiments were used to verify the expression levels and receiver operating characteristic (ROC) curves of these three target genes. Furthermore, immune invasiveness, pan-cancer, and mRNA-miRNA interaction network analyses were performed. Results: Eighty-nine genes showed increased expression and 190 genes showed decreased expression. Notably, the upregulated DEGs were predominantly associated with organelle fission and nuclear division, whereas the downregulated DEGs were mainly associated with genitourinary system development and cell-substrate adhesion. The construction of the DEG protein-protein interaction network revealed 32 and 19 hub genes with the highest moderate values among the upregulated and downregulated genes, respectively. Using random forest and LASSO regression analyses, the hub genes were employed to identify three most significant target genes.TCGA database and qPCR experiments were used to verify the expression levels and ROC curves of these three target genes, and immunoinvasive analysis, pan-cancer analysis and mRNA-miRNA interaction network analysis were performed. Conclusion: Three target genes identified by machine learning: BUB1B, CENPF, and PLK1 play key roles in LUAD development of lung adenocarcinoma.

Predicting the Lung Adenocarcinoma and Its Biomarkers by Integrating Gene Expression and DNA Methylation Data.

Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis

Multi-omics with Dynamic Network Biomarker Algorithm Prefigures Organ-Specific Metastasis of Lung Adenocarcinoma

Identification of Genes Associated with Lung Adenocarcinoma Prognosis

Machine learning and bioinformatics analysis of diagnostic biomarkers associated with the occurrence and development of lung adenocarcinoma

Identification and Validation of Novel DNA Methylation Markers for Early Diagnosis of Lung Adenocarcinoma.

Integrative Analysis of DNA Methylomes Reveals Novel Cell-Free Biomarkers in Lung Adenocarcinoma.

Differentially Expressed Mutant Genes Reveal Potential Prognostic Markers For Lung Adenocarcinoma.

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma

Integrative Analysis of Methylation and Gene Expression in Lung Adenocarcinoma and Squamous Cell Lung Carcinoma

Identification of DNA Methylation Signatures for Diagnosis of Lung Adenocarcinoma.

A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma

Screening prognostic markers for non-small cell lung cancer based on data mining and bioinformatics analysis

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis

A Functional Methylation Signature to Predict the Prognosis of Chinese Lung Adenocarcinoma Based on TCGA

Identification of Diagnostic DNA Methylation Biomarkers Specific for Early-Stage Lung Adenocarcinoma.

DNA Methylation Profiling Analysis Identifies a DNA Methylation Signature for Predicting Prognosis and Recurrence of Lung Adenocarcinoma

Identification of Pivotal Genes with Prognostic Evaluation Value in Lung Adenocarcinoma by Bioinformatics Analysis